SCHEMBL28635345

SCHEMBL28635345

CC(CNc1ccc(Br)cn1)COC(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
RAB9A P51151 10/20 0.41
MAPT P10636 2/20 0.40
TSHR P16473 2/20 0.40
NPC1 O15118 8/20 0.40
ATM Q13315 1/20 0.40
PKM P14618 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
FDPS P14324 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28622479 0.79 FDPS (0.49) RAB9ANPC1PKMSMN1; SMN2GAA
SCHEMBL28627403 0.79 PCSK9 (0.56) ATM
SCHEMBL22230134 0.77 HCAR3 (0.49) HCAR3HCAR2RAB9AMAPTTSHR
SCHEMBL28541779 0.77 HCAR3 (0.46) HCAR3RAB9AMAPTTSHRNPC1
SCHEMBL22229998 0.76 GPR35 (0.40) HCAR3HCAR2
SCHEMBL28631661 0.76 PCSK9 (0.58) HCAR3HCAR2
SCHEMBL28617445 0.76 F10 (0.41) HCAR3HCAR2
SCHEMBL28622420 0.75 PCSK9 (0.57) PKMSMN1; SMN2FDPSALDH1A1
SCHEMBL28539858 0.75 RAB9A (0.45) HCAR3RAB9AMAPTTSHRNPC1
SCHEMBL7904169 0.74 SMN1; SMN2 (0.51) HCAR3HCAR2RAB9AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113574055-A PCSK9 inhibitors and methods of use thereof 阿斯利康(瑞典)有限公司 2021-10-29 CN disclosed
CN-113412258-A PCSK9 inhibitors and methods of use thereof 阿斯利康(瑞典)有限公司 2021-09-17 CN disclosed